255 related articles for article (PubMed ID: 24076776)
1. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas.
Ballester LY; Wang Z; Shandilya S; Miettinen M; Burger PC; Eberhart CG; Rodriguez FJ; Raabe E; Nazarian J; Warren K; Quezado MM
Am J Surg Pathol; 2013 Sep; 37(9):1357-64. PubMed ID: 24076776
[TBL] [Abstract][Full Text] [Related]
2. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
[TBL] [Abstract][Full Text] [Related]
3. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.
Buczkowicz P; Bartels U; Bouffet E; Becher O; Hawkins C
Acta Neuropathol; 2014 Oct; 128(4):573-81. PubMed ID: 25047029
[TBL] [Abstract][Full Text] [Related]
4. Diffuse intrinsic pontine gliomas: treatments and controversies.
Bredlau AL; Korones DN
Adv Cancer Res; 2014; 121():235-259. PubMed ID: 24889533
[TBL] [Abstract][Full Text] [Related]
5. Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry.
Badhe PB; Chauhan PP; Mehta NK
Indian J Cancer; 2004; 41(4):170-4. PubMed ID: 15659871
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas.
Anderson JL; Muraleedharan R; Oatman N; Klotter A; Sengupta S; Waclaw RR; Wu J; Drissi R; Miles L; Raabe EH; Weirauch ML; Fouladi M; Chow LM; Hoffman L; DeWire M; Dasgupta B
Neuro Oncol; 2017 Aug; 19(8):1068-1078. PubMed ID: 28339768
[TBL] [Abstract][Full Text] [Related]
7. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.
Barrow J; Adamowicz-Brice M; Cartmill M; MacArthur D; Lowe J; Robson K; Brundler MA; Walker DA; Coyle B; Grundy R
Neuro Oncol; 2011 Feb; 13(2):212-22. PubMed ID: 21138945
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
9. Diffuse intrinsic pontine tumors: a study of primitive neuroectodermal tumors versus the more common diffuse intrinsic pontine gliomas.
Sufit A; Donson AM; Birks DK; Knipstein JA; Fenton LZ; Jedlicka P; Hankinson TC; Handler MH; Foreman NK
J Neurosurg Pediatr; 2012 Aug; 10(2):81-8. PubMed ID: 22747092
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.
Porkholm M; Valanne L; Lönnqvist T; Holm S; Lannering B; Riikonen P; Wojcik D; Sehested A; Clausen N; Harila-Saari A; Schomerus E; Thorarinsdottir HK; Lähteenmäki P; Arola M; Thomassen H; Saarinen-Pihkala UM; Kivivuori SM
Pediatr Blood Cancer; 2014 Sep; 61(9):1603-9. PubMed ID: 24692119
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
[No Abstract] [Full Text] [Related]
12. Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma.
Maxwell R; Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Bettegowda C; Jallo GI; Terezakis SA; Groves ML
World Neurosurg; 2018 Nov; 119():e1006-e1015. PubMed ID: 30138731
[TBL] [Abstract][Full Text] [Related]
13. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.
Macy ME; Kieran MW; Chi SN; Cohen KJ; MacDonald TJ; Smith AA; Etzl MM; Kuei MC; Donson AM; Gore L; DiRenzo J; Trippett TM; Ostrovnaya I; Narendran A; Foreman NK; Dunkel IJ
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544128
[TBL] [Abstract][Full Text] [Related]
14. Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.
Infinger LK; Stevenson CB
Curr Neuropharmacol; 2017; 15(1):129-133. PubMed ID: 27109746
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.
Panditharatna E; Yaeger K; Kilburn LB; Packer RJ; Nazarian J
Cancer Genet; 2015; 208(7-8):367-73. PubMed ID: 26206682
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma.
Paugh BS; Broniscer A; Qu C; Miller CP; Zhang J; Tatevossian RG; Olson JM; Geyer JR; Chi SN; da Silva NS; Onar-Thomas A; Baker JN; Gajjar A; Ellison DW; Baker SJ
J Clin Oncol; 2011 Oct; 29(30):3999-4006. PubMed ID: 21931021
[TBL] [Abstract][Full Text] [Related]
17. Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review.
Dalmage M; LoPresti MA; Sarkar P; Ranganathan S; Abdelmageed S; Pagadala M; Shlobin NA; Lam S; DeCuypere M
J Neurosurg Pediatr; 2023 Dec; 32(6):665-672. PubMed ID: 37724839
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA
Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876
[TBL] [Abstract][Full Text] [Related]
19. Brain stem gliomas: a clinicopathological study from a single cancer center.
Al-Hussaini M; Al-Jumaily U; Swaidan M; Musharbash A; Hashem S
Brain Tumor Pathol; 2013 Apr; 30(2):84-92. PubMed ID: 22752621
[TBL] [Abstract][Full Text] [Related]
20. Noncoding RNAs as potential biomarkers for DIPG diagnosis and prognosis: XIST and XIST-210 involvement.
Velázquez-Flores MÁ; Rodríguez-Corona JM; López-Aguilar JE; Siordia-Reyes G; Ramírez-Reyes G; Sánchez-Rodríguez G; Ruiz Esparza-Garrido R
Clin Transl Oncol; 2021 Mar; 23(3):501-513. PubMed ID: 32661825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
